The effect of adding ovarian function suppression to adjuvant endocrine therapy in premenopausal patients with hormone receptor-positive, HER2-positive breast cancer who have undergone neoadjuvant therapy: a single-center experience
- DOI
- 10.1186/s12885-026-17017-8
- Published
- 2026-09-21
- Container
- BMC Cancer
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s12885-026-17017-8,
title = {The effect of adding ovarian function suppression to adjuvant endocrine therapy in premenopausal patients with hormone receptor-positive, HER2-positive breast cancer who have undergone neoadjuvant therapy: a single-center experience},
author = {Okan Aydin and Hale Gulcin Yildirim Dogan and Sermin Dinc Sonusen and Mert Erciyestepe and Ahmet Emin Ozturk and Asli Buyukkuscu and Zehra Sucuoglu Isleyen and Kayhan Erturk},
year = {2026},
journal = {BMC Cancer},
doi = {10.1186/s12885-026-17017-8},
url = {https://doi.org/10.1186/s12885-026-17017-8}
}RIS
TY - JOUR TI - The effect of adding ovarian function suppression to adjuvant endocrine therapy in premenopausal patients with hormone receptor-positive, HER2-positive breast cancer who have undergone neoadjuvant therapy: a single-center experience AU - Okan Aydin AU - Hale Gulcin Yildirim Dogan AU - Sermin Dinc Sonusen AU - Mert Erciyestepe AU - Ahmet Emin Ozturk AU - Asli Buyukkuscu AU - Zehra Sucuoglu Isleyen AU - Kayhan Erturk PY - 2026 JO - BMC Cancer DO - 10.1186/s12885-026-17017-8 UR - https://doi.org/10.1186/s12885-026-17017-8 ER -
APA
Aydin, O., Dogan, H. G. Y., Sonusen, S. D., Erciyestepe, M., Ozturk, A. E., Buyukkuscu, A., Isleyen, Z. S., & Erturk, K. (2026). The effect of adding ovarian function suppression to adjuvant endocrine therapy in premenopausal patients with hormone receptor-positive, HER2-positive breast cancer who have undergone neoadjuvant therapy: a single-center experience. BMC Cancer. https://doi.org/10.1186/s12885-026-17017-8
Source records
- crossref · retrieved 2026-09-26T06:35:23.241Z